Overview of Dr. Mitchell Dr. Aaron Mitchell is an oncologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 5 years. He is one of 464 doctors at Memorial Sloan Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training University of North Carolina Hospitals Fellowship, Hematology and Medical Oncology, 2015 - 2018
Duke University Hospital Residency, Internal Medicine, 2011 - 2014
New York University School of Medicine Class of 2011
Certifications & Licensure FL State Medical License 2021 - Present
NJ State Medical License 2019 - 2025
NY State Medical License 2018 - 2025
NC State Medical License 2011 - 2019
American Board of Internal Medicine Internal Medicine American Board of Internal Medicine Medical Oncology Publications & Presentations PubMed
Commercial Versus Medicaid Insurance and Use of High-Priced Anticancer Treatments.
Aaron P Mitchell, Alan C Kinlaw, Sharon Peacock-Hinton, Stacie B Dusetzina, Aaron N Winn, Hanna K Sanoff, Jennifer L Lund> ;The Oncologist. 2024 Mar 14 Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer.
Nemirovsky, D., Mishra Meza, A., Chakraborty, N., Persaud, S., Mitchell, A., Farooki, A., Morris, M.> ;JCO Oncology Practice. 2024 Mar 1 Characterization of accelerated approval status, trial endpoints and results, and recommendations in guidelines for oncology drug treatments from the National Comprehe...
Joshua D Wallach, Aaron P Mitchell, Joshua J Skydel, Joseph S Ross, Reshma Ramachandran, Maryam Mooghali> ;BMJ Medicine. 2024 Jan 1 Authors' reply to Laurent.
Winn, A., Mitchell, A.> ;BMJ. 2023 Dec 4 Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study.
Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, Niti U Trivedi, Peter B Bach, Aaron N Winn> ;BMJ. 2023 Oct 25 Physician knowledge, practice patterns, and barriers encountered regarding guideline-concordant use of bone modifying agents for prostate cancer.
Aaron P Mitchell, Sonia Persaud, Paul Palyca, Andrew Salner, Azeez Farooki, Jamie S Ostroff, Michael J Morris, Susan Chimonas> ;The Prostate. 2024 Feb 1 Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.
Erin F Gillespie, Joanna C Yang, Noah J Mathis, Catherine B Marine, Charlie White, Zhigang Zhang, Christopher A Barker, Rupesh Kotecha, Alyson McIntosh, Max Vaynrub, M...> ;Journal of Clinical Oncology. 2024 Jan 1 The cancer premium - explaining differences in prices for cancer vs non-cancer drugs with efficacy and epidemiological endpoints in the US, Germany, and Switzerland: a...
Miquel Serra-Burriel, Gellért Perényi, Yannic Laube, Aaron P Mitchell, Kerstin N Vokinger> ;Eclinicalmedicine. 2023 Jul 1 Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?
Aaron Mitchell, Ameet Sarpatwari, Peter B Bach> ;Journal of Health Politics, Policy and Law. 2022 Dec 1 Cost Savings and Increased Access With Ultra-Low-Dose Immunotherapy.
Aaron P Mitchell, Daniel A Goldstein> ;Journal of Clinical Oncology. 2023 Jan 10 Physician Payments from Pharmaceutical Companies Related to Cancer Drugs.
Aaron P Mitchell, Akriti Mishra Meza, Niti U Trivedi, Peter B Bach, Mithat Gönen> ;The Oncologist. 2022 Oct 1 Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer.
Aaron P Mitchell, Akriti Mishra Meza, Katherine S Panageas, Allison Lipitz-Snyderman, Azeez Farooki, Michael J Morris> ;Prostate Cancer and Prostatic Diseases. 2023 Mar 1 The Prescription Drug User Fee Act: Much More Than User Fees.
Aaron P Mitchell, Niti U Trivedi, Peter B Bach> ;Medical Care. 2022 Apr 1 Increasing Financial Payments From Industry to Medical Oncologists in the United States, 2014-2017.
Mohammed W Rahman, Niti U Trivedi, Peter B Bach, Aaron P Mitchell> ;Journal of the National Comprehensive Cancer Network. 2021 Dec 29 The Cost of Enfortumab Vedotin Wastage Due to Vial Size—A Real-World Analysis
Assaf Moore, Ashley Marie Regazzi, Aaron P. Mitchell, Jonathan E. Rosenberg> ;Cancers. 2021 Nov 27 Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Aaron P Mitchell, Akriti Mishra, Pranam Dey, Michael A Curry, Niti U Trivedi, Michael Haddadin, Mohammed W Rahman, Aaron N Winn, Stacie B Dusetzina, Peter B Bach> ;The Oncologist. 2021 Oct 1 Real-World Use of Bone Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer.
Aaron P. Mitchell, Akriti Mishra, Katherine S. Panageas, Allison Lipitz-Snyderman, Peter B. Bach, Michael J. Morris> ;Journal of the National Cancer Institute. 2021 Oct 1 We Should Treat Financial Toxicity With Curative, Rather Than Palliative, Intent
Aaron P. Mitchell> ;JCO Oncology Practice. 2021 Sep 21 Industry Payments to Rheumatologists Ought to Be Going Down, Not Up.
Aaron P. Mitchell> ;Arthritis & Rheumatology. 2021 Jun 23 Personal Payments from Pharmaceutical Companies to Authors of Oncology Clinical Practice Guidelines.
Aaron P Mitchell, Akriti Mishra, Pranam Dey, Michael A Curry, Niti U Trivedi, Michael Haddadin, Mohammed W Rahman, Aaron N Winn, Stacie B Dusetzina, Peter B Bach> ;The Oncologist. 2021 Sep 1 The Role of Physician Professional Networks in Physicians’ Receipt of Pharmaceutical and Medical Device Industries’ Payments
Aaron N. Winn, Aaron P. Mitchell, Nicole Fergestrom, Joan M. Neuner, Justin G. Trogdon> ;Journal of General Internal Medicine. 2021 Apr 26 Authors' Reply To Letter to the Editor by Cho and Jun.
Aaron P. Mitchell, Peter B. Bach> ;Journal of the National Comprehensive Cancer Network. 2021 Mar 2 Activation of EphA2-EGFR signaling in oral epithelial cells by Candida albicans virulence factors.
Marc Swidergall, Norma V. Solis, Nicolas Millet, Manning Y. Huang, Jianfeng Lin, Quynh T. Phan, Michael D. Lazarus, Zeping Wang, Michael R. Yeaman, Aaron P. Mitchell, ...> ;Plos Pathogens. 2021 Jan 20 Association between Site-of-Care and the Cost and Modality of Radiotherapy for Prostate Cancer: Analysis of Medicare Beneficiaries from 2015 to 2017.
Kathryn R. Tringale, Renee L. Gennarelli, Erin F. Gillespie, Aaron P. Mitchell, Michael J. Zelefsky> ;Cancer Investigation. 2021 Jan 8 Diminished Expression Alleles for Analysis of Virulence Traits and Genetic Interactions in Candida albicans.
Carol A. Woolford, Aaron P. Mitchell> ;Methods in Molecular Biology. 2021 Jan 1 Join now to see all Journal Articles
Function of BriC Peptide in the Pneumococcal Competence and Virulence Portfolio
Wenjie Xu, Aaron P Mitchell, PLoS One Press Mentions Study in India Could Make Immunotherapy More Affordable Worldwide November 22nd, 2022
Pharma-Funded FDA Gets Drugs Out Faster, but Some Work Only ‘Marginally’ and Most Are Pricey September 30th, 2022
F.D.A.’s Drug Industry Fees Fuel Concerns Over Influence September 15th, 2022
Join now to see all Grant Support Functional Analysis Of Essential C. Albicans Genes National Institute Of Allergy And Infectious Diseases 2012 Genetic Control Of C. Albicans Biofilm Formation National Institute Of Allergy And Infectious Diseases 2009–2012 PROTEIN-PROTEIN Interaction Test In Candida Albicans National Institute Of Allergy And Infectious Diseases 2009–2010 Genetic Control Of Entry Into Meiosis In Yeast National Institute Of Allergy And Infectious Diseases 2008–2010 Large-Scale Analysis Of Candida Albicans Gene Function National Institute Of Allergy And Infectious Diseases 2008 ASM Conference On Candida And Candidiasis National Institute Of Allergy And Infectious Diseases 2008 Genetic Control Of C. Albicans Biofilm Formation National Institute Of Allergy And Infectious Diseases 2006–2008 Molecular Mycology Summer Course National Institute Of Allergy And Infectious Diseases 2003–2008 Genetic Control Of Entry Into Meiosis In Yeast National Institute Of Allergy And Infectious Diseases 2006–2007 Large-Scale Analysis Of Candida Albicans Gene Function National Institute Of Allergy And Infectious Diseases 2004–2007 2006 Cellular &Molecular Fungal Biology Gordon Research Conference National Institute Of Allergy And Infectious Diseases 2006 Training Program In Microbiology For Infectious Diseases National Institute Of Allergy And Infectious Diseases 2004–2006 C. Albicans Regulatory Pathways In Oral Candidiasis National Institute Of Allergy And Infectious Diseases 2001–2005 New Strategies For Identification Of C. Albicans Fluconazole Resistance Gene National Institute Of Allergy And Infectious Diseases 2004 Genetic Control Of Entry Into Meiosis In Yeast National Institute Of General Medical Sciences 1995–2004 Identification Of C Albicans Fluconazole Resistance Gene National Institute Of Allergy And Infectious Diseases 2003 Identification And Evaluation Of Anti-Candida Vaccine Targets National Institute Of Allergy And Infectious Diseases 1999–2002 Genetic Control Of Entry Into Meiosis In Yeast National Institute Of General Medical Sciences 1988–1994 
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2015 - 2018
Duke University HospitalResidency, Internal Medicine, 2011 - 2014
New York University School of MedicineClass of 2011
FL State Medical License 2021 - Present
NJ State Medical License 2019 - 2025
NY State Medical License 2018 - 2025
NC State Medical License 2011 - 2019
Study in India Could Make Immunotherapy More Affordable WorldwideNovember 22nd, 2022
Memorial Sloan Kettering Cancer CenterNew York, New York
